SAGE Therapeutics Inc
NASDAQ:SAGE
Income Statement
Earnings Waterfall
SAGE Therapeutics Inc
Revenue
|
91.1m
USD
|
Cost of Revenue
|
-3.2m
USD
|
Gross Profit
|
87.9m
USD
|
Operating Expenses
|
-629.9m
USD
|
Operating Income
|
-542m
USD
|
Other Expenses
|
39m
USD
|
Net Income
|
-503.1m
USD
|
Income Statement
SAGE Therapeutics Inc
Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
90
N/A
|
90
N/A
|
90
+0%
|
91
+1%
|
2
-98%
|
5
+212%
|
7
+30%
|
9
+28%
|
9
+2%
|
7
-22%
|
1 114
+15 817%
|
1 114
0%
|
1 114
+0%
|
1 114
0%
|
6
-99%
|
6
-2%
|
6
-2%
|
6
+5%
|
8
+20%
|
9
+22%
|
10
+11%
|
11
+10%
|
86
+658%
|
91
+5%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
4
+425%
|
7
+55%
|
8
+23%
|
8
+3%
|
6
-23%
|
1 114
+17 576%
|
1 113
0%
|
1 114
+0%
|
1 113
0%
|
6
-99%
|
6
-2%
|
6
-4%
|
6
+5%
|
7
+19%
|
9
+26%
|
10
+11%
|
10
+2%
|
84
+751%
|
88
+4%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(21)
|
(22)
|
(27)
|
(34)
|
(45)
|
(64)
|
(79)
|
(95)
|
(109)
|
(118)
|
(132)
|
(160)
|
(187)
|
(223)
|
(259)
|
(273)
|
(294)
|
(335)
|
(389)
|
(484)
|
(576)
|
(641)
|
(703)
|
(715)
|
(678)
|
(612)
|
(531)
|
(490)
|
(482)
|
(452)
|
(475)
|
(467)
|
(493)
|
(513)
|
(524)
|
(554)
|
(588)
|
(631)
|
(668)
|
(631)
|
(630)
|
|
Selling, General & Administrative |
(5)
|
(6)
|
(8)
|
(10)
|
(12)
|
(17)
|
(21)
|
(25)
|
(28)
|
(31)
|
(33)
|
(39)
|
(45)
|
(51)
|
(58)
|
(63)
|
(80)
|
(108)
|
(145)
|
(201)
|
(257)
|
(302)
|
(336)
|
(346)
|
(332)
|
(282)
|
(229)
|
(197)
|
(167)
|
(172)
|
(185)
|
(184)
|
(190)
|
(199)
|
(212)
|
(228)
|
(247)
|
(270)
|
(287)
|
(275)
|
(261)
|
|
Research & Development |
(16)
|
(17)
|
(20)
|
(24)
|
(33)
|
(47)
|
(58)
|
(69)
|
(80)
|
(88)
|
(99)
|
(121)
|
(142)
|
(172)
|
(201)
|
(210)
|
(214)
|
(228)
|
(244)
|
(282)
|
(319)
|
(339)
|
(366)
|
(369)
|
(346)
|
(330)
|
(302)
|
(293)
|
(287)
|
(280)
|
(290)
|
(283)
|
(303)
|
(314)
|
(312)
|
(326)
|
(341)
|
(361)
|
(381)
|
(356)
|
(335)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(28)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(33)
|
|
Operating Income |
(21)
N/A
|
(22)
-7%
|
(27)
-23%
|
(34)
-24%
|
(45)
-33%
|
(64)
-42%
|
(79)
-23%
|
(95)
-21%
|
(109)
-15%
|
(118)
-9%
|
(132)
-12%
|
(160)
-21%
|
(187)
-17%
|
(223)
-19%
|
(259)
-16%
|
(273)
-5%
|
(294)
-8%
|
(245)
+17%
|
(299)
-22%
|
(393)
-31%
|
(485)
-23%
|
(639)
-32%
|
(698)
-9%
|
(708)
-1%
|
(670)
+5%
|
(604)
+10%
|
(525)
+13%
|
624
N/A
|
631
+1%
|
662
+5%
|
639
-4%
|
(461)
N/A
|
(488)
-6%
|
(508)
-4%
|
(519)
-2%
|
(547)
-5%
|
(579)
-6%
|
(621)
-7%
|
(658)
-6%
|
(546)
+17%
|
(542)
+1%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
6
|
10
|
15
|
20
|
23
|
26
|
28
|
28
|
26
|
21
|
15
|
10
|
6
|
4
|
3
|
3
|
3
|
5
|
8
|
14
|
22
|
30
|
36
|
39
|
39
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(28)
|
(28)
|
(28)
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(34)
|
(33)
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Pre-Tax Income |
(21)
N/A
|
(22)
-7%
|
(27)
-23%
|
(34)
-24%
|
(45)
-33%
|
(64)
-42%
|
(78)
-23%
|
(95)
-21%
|
(108)
-14%
|
(118)
-9%
|
(132)
-12%
|
(159)
-21%
|
(185)
-16%
|
(221)
-19%
|
(257)
-16%
|
(270)
-5%
|
(288)
-7%
|
(235)
+18%
|
(284)
-21%
|
(373)
-31%
|
(462)
-24%
|
(613)
-33%
|
(670)
-9%
|
(680)
-2%
|
(644)
+5%
|
(612)
+5%
|
(537)
+12%
|
606
N/A
|
637
+5%
|
666
+5%
|
642
-4%
|
(458)
N/A
|
(484)
-6%
|
(503)
-4%
|
(510)
-1%
|
(533)
-4%
|
(558)
-5%
|
(592)
-6%
|
(656)
-11%
|
(541)
+17%
|
(503)
+7%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(21)
|
(22)
|
(27)
|
(34)
|
(45)
|
(64)
|
(78)
|
(95)
|
(108)
|
(118)
|
(132)
|
(159)
|
(185)
|
(221)
|
(257)
|
(270)
|
(288)
|
(235)
|
(284)
|
(373)
|
(462)
|
(613)
|
(670)
|
(680)
|
(644)
|
(612)
|
(537)
|
606
|
637
|
666
|
642
|
(458)
|
(484)
|
(503)
|
(510)
|
(533)
|
(558)
|
(592)
|
(656)
|
(541)
|
(503)
|
|
Net Income (Common) |
(21)
N/A
|
(24)
-15%
|
(30)
-22%
|
(36)
-22%
|
(47)
-30%
|
(64)
-37%
|
(78)
-22%
|
(95)
-21%
|
(108)
-14%
|
(118)
-9%
|
(132)
-12%
|
(159)
-21%
|
(185)
-16%
|
(221)
-19%
|
(257)
-16%
|
(270)
-5%
|
(288)
-7%
|
(235)
+18%
|
(284)
-21%
|
(373)
-31%
|
(462)
-24%
|
(613)
-33%
|
(670)
-9%
|
(680)
-2%
|
(644)
+5%
|
(612)
+5%
|
(537)
+12%
|
606
N/A
|
637
+5%
|
666
+5%
|
642
-4%
|
(458)
N/A
|
(484)
-6%
|
(503)
-4%
|
(510)
-1%
|
(533)
-4%
|
(558)
-5%
|
(592)
-6%
|
(656)
-11%
|
(541)
+17%
|
(503)
+7%
|
|
EPS (Diluted) |
-0.88
N/A
|
-1.01
-15%
|
-1.5
-49%
|
-1.67
-11%
|
-1.82
-9%
|
-2.3
-26%
|
-2.72
-18%
|
-3.4
-25%
|
-3.42
-1%
|
-3.66
-7%
|
-3.98
-9%
|
-4.75
-19%
|
-4.96
-4%
|
-5.9
-19%
|
-6.84
-16%
|
-7.09
-4%
|
-6.49
+8%
|
-5.04
+22%
|
-6.07
-20%
|
-8.08
-33%
|
-9.51
-18%
|
-11.94
-26%
|
-12.95
-8%
|
-13.38
-3%
|
-12.4
+7%
|
-11.8
+5%
|
-10.35
+12%
|
11.43
N/A
|
10.9
-5%
|
11.36
+4%
|
10.91
-4%
|
-7.8
N/A
|
-8.2
-5%
|
-8.48
-3%
|
-8.59
-1%
|
-8.98
-5%
|
-9.33
-4%
|
-9.89
-6%
|
-10.94
-11%
|
-9.05
+17%
|
-8.36
+8%
|